In South Africa, there are numerous governance structures that make crucial decisions about selection, procurement, distribution, and use of medicines, diagnostics, and other pharmaceutical products. A challenge commonly encountered is that critical committees either do not exist or where the committee is in place, it does not function optimally. One of the most underlying causes of poor functioning of committees is the absence of or weak terms of reference (TOR). In 2015, the Affordable Medicines Directorate (AMD) of South Africa’s National Department of Health (NDOH), requested assistance from SIAPS in strengthening the TOR of several national committees, including those involved in selection of medicines for inclusion on the National Essential Medicines List (NEML). SIAPS developed a TOR guidance document that can be used in the development or review of TOR. The purpose of this brief is to share the guidance document and the processes SIAPS and their counterparts followed to develop new and revise existing TOR for three different pharmaceutical sector committees in South Africa.
Developing Better Terms of Reference to Improve the Performance of Pharmaceutical Sector Committees: Case Studies from South Africa
Pharmaceutical Leadership and Governance Initiative in the Free State Province, November 2015–May 2016
The PLGI was implemented in the Free State Province from September 2015 to May 2016. Thirty-two pharmacists from primary health care (PHC) centers, hospitals, districts, and the provincial health depot successfully completed the program. The results achieved, together with the challenges faced by the pharmacy district teams, were presented at a final presentation workshop held in Bloemfontein in May 2016.
The LDP was offered to health care professionals in the Northern/Tygerberg Sub-Structure (NTSS), Western Cape Province. Twenty-four health care professionals (12 facility managers and 12 pharmacy supervisors) from primary health care facilities across the sub-structure were enrolled in the program in September 2012. The results achieved, together with the challenges faced by the NTSS facility teams, were presented at a final presentation workshop held in Cape Town in November 2014. Seven of the twelve teams (58%) had achieved their desired measurable results by the end of the six-month period.
The Pharmaceutical Leadership Development Program (PLDP) is a participatory training program using innovative strategies to strengthen health care professionals’ leadership and management skills. Based on the framework behind Management Sciences for Health (MSH)’s Leadership Development Program, the PLDP was developed at the request of South Africa’s provincial heads of Pharmaceutical Services to strengthen pharmacy managers’ leadership capacities and target key pharmaceutical management challenges.
The PLDP is delivered in a series of five workshops over a period of six to seven months. As an integral part of the program, participants, who work at different levels of service delivery, develop quality-improvement projects aimed at addressing a key challenge experienced within their workplace. Participants bring what they learn back to their workplaces, where they teach and inspire their coworkers to apply these practices to real challenges in priority health system strengthening areas. PLDP coaches provide feedback and support throughout the process.
The technical report describes the approach to the design and implementation of the PLDP in South Africa. The report shares lessons learned and efforts taken for sustainability and ownership.
SIAPS Program Director’s Blog: Strengthening the Leadership and Management of Pharmaceutical Services in South Africa
In South Africa, the USAID funded SIAPS Program has provided technical assistance in leadership and management to improve the pharmaceutical sector. Through close collaboration with the government of South Africa, SIAPS adapted MSH’s Virtual Leadership Development Program (VLDP), creating the Pharmaceutical Leadership Development Program (PLDP). The PLDP combines technical pharmaceutical knowledge with training in leading […]
Technical Brief: Strengthening the Leadership and Management of Pharmaceutical Services in South Africa
South Africa’s health system is under enormous strain. There is a sizeable and increasing number of people with chronic diseases, both communicable and noncommunicable. The country has the largest population living with HIV, estimated at 7 million; an HIV prevalence rate of 19.2%; and 180,000 HIV-related deaths in 2015. South Africa has the highest number of people on HIV treatment—nearly 2.6 million—and has committed to nearly doubling that number in the next few years. It also has a significant burden of tuberculosis (TB), including multi- and extensively-drug resistant TB.
According to the World Health Organization, South Africa ranks third in terms of TB burden, after India and China.3 There is also high maternal, neonatal, and child mortality. In partnership with civil society and development organizations, the country has made significant strides in reducing the tide of HIV, AIDS, and TB, thereby contributing to an increase in life expectancy. Nevertheless, the effectiveness and efficiency of the country’s health system remain a huge challenge. The burden of communicable and non-communicable diseases and the rapidly growing patient population have considerable implications for the delivery of pharmaceutical services.
Strengthening Local Capacity to Establish or Improve Performance of Drug and Therapeutics Committees in Low- and Middle-Income Countries
Getahun W., Berrada S., Joshi M.P., Mulongo R., Tuala Tuala R., Shongwe K., Ludman M., Bay N. Strengthening Local Capacity to Establish or Improve Performance of Drug and Therapeutics Committees in Low- and Middle-Income Countries. Poster presented at the 75th International Pharmaceutical Federation (FIP) World Congress, Dusseldorf, Germany, 29 September to 3 October 2015.
Capacity building strategies to improve efficient use of existing resources: The South African experience
The efficient use of existing resources is an essential component of a sustainable and resilient pharmaceutical system. SIAPS-South Africa has used various capacity-building strategies to improve the decision-making process in the selection of cost-effective and affordable medicines for the public sector, and to promote the monitoring and analysis of pharmaceutical expenditure. To that effect, SIAPS-South […]
Interfacing RxSolution with a Biometric Verification System to Improve Patient Records Management in South Africa
Enhancing patient recordkeeping in Tshwane Metropolitan Municipality The City of Tshwane Metropolitan Municipality, located in the Gauteng Province, is the fifth-largest municipality in South Africa and home to over 2.9 million residents as well as the capital, Pretoria. The municipality operates 24 primary health care facilities providing access to health services, primarily to the uninsured […]
“Antimicrobial resistance (AMR) is a major threat to the long-term security of public health and has the potential to negatively impact our society. It is a serious and growing global health security risk, which needs to be prioritised at local and international levels.”- Dr. Aaron Motsoaledi, South African Minister of Health In May 2014, the […]
- Rapport de quantification des produits de la santé reproductive, maternelle, néonatale et infantile pour la période de janvier 2017 à décembre 2020
La présente activité avait pour objectif d’apporter un soutien au Ministère de la Santé et de l’Hygiène publique (MSHP) pour […]
Project dates: September 2012 – December 2016
The Department of Health-Pharmaceutical Division (DOH-PD) and National TB Program (NTP) in the Philippines adopted the web‐based application Pharmacovigilance Monitoring […]